New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 15, 2012
08:57 EDTTRGT, ARQLTargacept names Stephen A. Hill, M.D., president and CEO
Dr. Hill is expected to start with Targacept (TRGT) on December 1 and will also join Targaceptís Board of Directors. Dr. Hill brings over 20 years of industry experience to the role, having served previously as President and Chief Executive Officer of Solvay Pharmaceuticals, Inc. and ArQule (ARQL). Upon Dr. Hill joining Targacept, the previously formed Office of the Chairman will be dissolved.
News For TRGT;ARQL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for TRGT;ARQL

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use